Intera Oncology is a rapidly growing Boston-based life science company whose mission is to change the course of cancer for patients with colorectal cancer and cholangiocarcinoma.

The company’s flagship product is the Intera 3000 Hepatic Artery Infusion Pump - a palm-sized, implantable device that delivers a continuous flow of chemotherapy via hepatic artery directly to tumors in the liver. This allows patients to go about their normal daily activities outside of a hospital with minimal disruption to their lives while receiving therapy.

In addition, Intera Oncology is developing innovative new solutions for treatment of diseases with significant unmet medical needs.